Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-046807

Chairman and CEO bought 5,300 shares at an average $1.51 ($7,986)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-07-13 Purchase +1,800 $1.52 $2,736 10,789,371 D
Niihara Yutaka Chairman and CEO 2021-07-14 Purchase +1,300 $1.50 $1,950 10,790,671 D
Niihara Yutaka Chairman and CEO 2021-07-15 Purchase +2,200 $1.50 $3,300 10,792,871 D
Open-market purchases · 5,300 sh · avg $1.51 · $7,986
Loading xslF345X03/doc4.xml…